Hormesis, biological plasticity, and implications for clinical trial research
Ageing Research Reviews · 2023-09 · 90 · 102028
DOI: 10.1016/j.arr.2023.102028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ageing Research Reviews, 2023-09. Verfasst von Edward J Calabrese und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Sciences, Morrill I, N344, University of Massachusetts, Amherst, MA 01003, USA. Electronic address: edwardc@school…. Hauptthemen laut MEDLINE: Hormesis, Clinical Trials as Topic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NCATS NIH HHS, Air Force Office of Scientific Research, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
The present paper identifies a critical factor that leads to false negative results (i.e., failing to indicate efficacy when beneficial results did occur) in randomized human drug trials. The paper demonstrates that human performance can only be enhanced by a maximum of 30-60% as described by the hormetic dose response which defines the limits of biological plasticity. However, human epidemiological/clinical trials typically contain such extensive variability that often requires responses greater than 2-3 times control group responses to show statistical significance. Thus, many potentially beneficial agents may be missed because the clinical trial fails to recognize and take into consideration the limits of biological plasticity. The paper proposes that this hormesis-biological plasticity-clinical trial conundrum can be addressed successfully via the use of a weight-of-evidence methodology similar to that used by regulatory agencies such as EPA in environmental assessment of chemical toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Environmental Health Sciences, Morrill I, N344, University of Massachusetts, Amherst, MA 01003, USA. Electronic address: edwardc@schoolph.umass.edu.
- University of Maine, 5728 Fernald Hall, Room 201, Orono, ME 04469, USA.
- Center for Environmental Occupational Risk Analysis and Management, College of Public Health, University of South Florida, Tampa, FL, USA.
- Stantec (ChemRisk), Boston, MA, USA.
- Saint Francis Hospital and Medical Center, Hartford, CT, USA.
- Department of Biomedical and Biotechnological Sciences, School of Medicine University of Catania, Via Santa Sofia 97, Catania 95123, Italy.
Förderung
- NCATS NIH HHS
- Air Force Office of Scientific Research
- National Center for Advancing Translational Sciences
- ExxonMobil Foundation
- National Science Foundation
- U.S. Air Force
- National Institutes of Health
- U.S. Department of Health and Human Services
Zitieren
APA
Calabrese, E. J., Pressman, P., Hayes, A. W., Dhawan, G., Kapoor, R., Calabrese, V., Agathokleous, E., Iavicoli, I., & Giordano, J. (2023). Hormesis, biological plasticity, and implications for clinical trial research. Ageing Research Reviews, 90, 102028. https://doi.org/10.1016/j.arr.2023.102028
Vancouver
Calabrese EJ, Pressman P, Hayes AW, Dhawan G, Kapoor R, Calabrese V, et al. Hormesis, biological plasticity, and implications for clinical trial research. Ageing Research Reviews. 2023;90:102028. doi:10.1016/j.arr.2023.102028
BibTeX
@article{Calabrese2023,
author = {Calabrese, Edward J and Pressman, Peter and Hayes, A Wallace and Dhawan, Gaurav and Kapoor, Rachna and Calabrese, Vittorio and Agathokleous, Evgenios and Iavicoli, Ivo and Giordano, James},
title = {Hormesis, biological plasticity, and implications for clinical trial research},
journal = {Ageing Research Reviews},
year = {2023},
volume = {90},
pages = {102028},
doi = {10.1016/j.arr.2023.102028}
}
EUVIMED